November 11, 2020
1 min watch
Save
VIDEO: Liquid biopsies integrate molecular testing into NSCLC management
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Charu Aggarwal, MD, MPH, Leslye M. Heisler assistant professor for lung cancer excellence at the University of Pennsylvania Abramson Cancer Center, discusses the role of liquid biopsies for the management of non-small cell lung cancer.
Aggarwal presented recent advances in the field during this year’s Chemotherapy Foundation Symposium.
“I’m really excited to share the recent advances that we have made and our ability to integrate molecular testing into our treatment paradigms,” she said.
References:
- Aggarwal C, et al. Medical Crossfire: Making Sense of Competing Frontline Strategies in Metastatic Lung Cancer. Presented at: Chemotherapy Foundation Symposium; Nov. 4-6, 2020.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Aggarwal reports consultant roles with AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech and Merck.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.